These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1004706)

  • 1. Vesicular noradrenaline in nerve terminals of rat heart following inhibition of monoamine oxidase and administration of noradrenaline.
    Fillenz M; Howe PR; West DP
    Neuroscience; 1976; 1(2):113-6. PubMed ID: 1004706
    [No Abstract]   [Full Text] [Related]  

  • 2. Vesicular noradrenaline stores in peripheral nerves of the rat and their modification by tranylcypromine.
    Fillenz M; Stanford SC
    Br J Pharmacol; 1981 Jun; 73(2):401-4. PubMed ID: 7236991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in the vesicular noradrenaline of nerve terminals.
    Fillenz M; Howe PR
    J Physiol; 1971; 217 Suppl():27P-28P. PubMed ID: 5571930
    [No Abstract]   [Full Text] [Related]  

  • 4. SLC10A4 is a vesicular amine-associated transporter modulating dopamine homeostasis.
    Larhammar M; Patra K; Blunder M; Emilsson L; Peuckert C; Arvidsson E; Rönnlund D; Preobraschenski J; Birgner C; Limbach C; Widengren J; Blom H; Jahn R; Wallén-Mackenzie Å; Kullander K
    Biol Psychiatry; 2015 Mar; 77(6):526-36. PubMed ID: 25176177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Various effects of monoamine oxidase inhibitors under conditions of complete monoamine oxidase inhibition on the serotonin, dopamine and noradrenaline levels in the rat brain].
    Matthies H; Popov N
    Acta Biol Med Ger; 1966; 17(4):488-97. PubMed ID: 5983631
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for the presence of dopamine- -hydroxylase in both populations of noradrenaline storage vesicles in sympathetic nerve terminals of the rat vas deferens.
    Bisby MA; Fillenz M; Smith AD
    J Neurochem; 1973 Jan; 20(1):245-8. PubMed ID: 4734484
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of vesicular storage and monoamine oxidase activity on [11C]phenylephrine kinetics: studies in isolated rat heart.
    Raffel DM; Wieland DM
    J Nucl Med; 1999 Feb; 40(2):323-30. PubMed ID: 10025842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 6-hydroxydopamine on rat heart noradrenaline.
    Corrodi H; Masuoka DT; Clark WG
    Eur J Pharmacol; 1971 Jul; 15(2):160-3. PubMed ID: 5153842
    [No Abstract]   [Full Text] [Related]  

  • 9. 4-Methoxytranylcypromine, a monoamine oxidase inhibitor: effects on biogenic amines in rat brain following chronic administration.
    Sherry-McKenna RL; Baker GB; Mousseau DD; Coutts RT; Dewhurst WG
    Biol Psychiatry; 1992 May; 31(9):881-8. PubMed ID: 1353376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of vesicular dopamine and norepinephrine by monoamine oxidase inhibitors.
    Buu NT
    Biochem Pharmacol; 1989 May; 38(10):1685-92. PubMed ID: 2730683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

  • 12. Maturation of sympathetic neurotransmission in the rat heart--III. Developmental changes in reserpine inhibition of norepinephrine uptake into isolated synaptic vesicles.
    Bareis DL; Slotkin TA
    Biochem Pharmacol; 1980 Jun; 29(11):1595-8. PubMed ID: 6249322
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of cold exposure on the activities of soluble and membrane-bound dopamine beta-hydroxylase in rat heart vesicles.
    Brodde OE; Huvermann K; Schümann HJ
    J Neurochem; 1976 Aug; 27(2):433-8. PubMed ID: 965985
    [No Abstract]   [Full Text] [Related]  

  • 14. Brain amine concentrations after monoamine oxidase inhibitor administration.
    Jones AB; Pare CM; Nicholson WJ; Price K; Stacey RS
    Br Med J; 1972 Jan; 1(5791):17-9. PubMed ID: 5008339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that the rapid binding of newly accumulated noradrenaline within synaptosomes involves synaptic vesicles.
    White TD
    Brain Res; 1976 May; 108(1):87-96. PubMed ID: 6114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of normetanephrine and norepinephrine by cocaine-treated rat heart.
    Simmonds MA; Gillis CN
    J Pharmacol Exp Ther; 1968 Feb; 159(2):283-9. PubMed ID: 5638649
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of ascorbic acid on release of acetylcholine from synaptic vesicles prepared from different species of animals and release of noradrenaline from synaptic vesicles of rat brain.
    Kuo CH; Hata F; Yoshida H; Yamatodani A; Wada H
    Life Sci; 1979 Mar; 24(10):911-5. PubMed ID: 109717
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of tyramine and guanethidine on dopamine-beta-hydroxylase activity and norepinephrine concentrations in vesicular fraction of the heart and plasma of rats.
    Grobecker H; Roizen MF; Kopin IJ
    Life Sci; 1977 Mar; 20(6):1009-15. PubMed ID: 850457
    [No Abstract]   [Full Text] [Related]  

  • 19. N-(2-cyanoethyl)tranylcypromine, a potential prodrug of tranylcypromine: its disposition and interaction with catecholamine neurotransmitters in brain.
    Nazarali AJ; Baker GB; Coutts RT; Wong TF
    Pharm Res; 1987 Feb; 4(1):16-20. PubMed ID: 3508523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of the chronotropic effect of tyramine on rat atria after reserpine.
    Murnaghan MF
    Br J Pharmacol; 1968 Sep; 34(1):88-98. PubMed ID: 4877602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.